Insulet Corporation Surges to 291st in Trading Volume with $319 Million in Shares Exchanged

On May 22, 2025, Insulet Corporation (PODD) saw a significant surge in trading volume, with a total of $319 million in shares exchanged, marking a 50.23% increase from the previous day. This substantial trading activity placed Insulet among the top 291 most actively traded stocks for the day.

Insulet Corporation, headquartered in Acton, Massachusetts, is a pioneering medical device company established in 2000. The company's mission is to enhance the quality of life for individuals through innovative medical solutions.

Citigroup analyst Joanne Wuensch maintained a "Buy" rating on Insulet and raised the price target from $320.00 to $380.00, reflecting an 18.75% increase. This adjustment underscores a positive outlook for the company, aligning with its current market trajectory and indicating confidence in its performance and potential growth.

Silvercrest Asset Management Group LLC increased its holdings in Insulet by 18.1% during the fourth quarter, demonstrating continued investor interest and support for the company's prospects.